XWEL XWELL Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: XWEL

Price (delayed)

$0.9025

Market cap

$7.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.32

Enterprise value

$2.7M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

XWELL, Inc. is a leading global wellness holding company operating multiple brands: XpresSpa®, Treat™, Naples Wax Center®, XpresCheck® and HyperPointe™. XpresSpa is a leading retailer of wellness services and related ...

Highlights
The gross margin has soared by 67% YoY and by 16% from the previous quarter
XWELL's equity has soared by 64% YoY
The quick ratio has soared by 105% YoY but it has contracted by 2.7% from the previous quarter
XWEL's EPS is down by 30% year-on-year but it is up by 5% since the previous quarter
The net income has declined by 21% year-on-year
XWELL's revenue has decreased by 8% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.xpresspagroup.com
Peers: PRGO

Key stats

What are the main financial stats of XWEL

XWEL stock price

How has the XWELL stock price performed over time
Intraday
1.12%
1 week
-0.28%
1 month
-13.22%
1 year
-17.95%
YTD
95.86%
QTD
-13.22%

Financial performance

How have XWELL's revenue and profit performed over time
Revenue
$28.28M
Gross profit
$9.71M
Operating income
-$17.34M
Net income
-$23.45M
Gross margin
34.3%
Net margin
-82.9%
The gross margin has soared by 67% YoY and by 16% from the previous quarter
The gross profit has soared by 55% YoY and by 14% from the previous quarter
XWELL's net margin has decreased by 31% YoY
The net income has declined by 21% year-on-year

Price vs fundamentals

How does XWEL's price correlate with its fundamentals

Growth

What is XWELL's growth rate over time

Valuation

What is XWELL stock price valuation
P/E
N/A
P/B
N/A
P/S
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.1
XWEL's EPS is down by 30% year-on-year but it is up by 5% since the previous quarter
XWELL's equity has soared by 64% YoY
XWEL's price to sales (P/S) is 61% less than its 5-year quarterly average of 0.7 but 35% more than its last 4 quarters average of 0.2
XWELL's revenue has decreased by 8% YoY

Efficiency

How efficient is XWELL business performance
The return on invested capital has dropped by 150% year-on-year and by 15% since the previous quarter
The company's return on assets has shrunk by 119% YoY
XWEL's return on sales is down by 30% year-on-year

Dividends

What is XWEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XWEL.

Financial health

How did XWELL financials performed over time
XWEL's total assets is 67% greater than its total liabilities
The quick ratio has soared by 105% YoY but it has contracted by 2.7% from the previous quarter
The company's current ratio has surged by 82% YoY but it fell by 3.4% QoQ
The debt to equity has plunged by 118% from the previous quarter and by 104% YoY
XWELL's equity has soared by 64% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.